Marco Severgnini Selected Research

Marco Severgnini Research Topics

5	Neoplasms (Cancer) 11/2023 - 05/2006
4	Infections 10/2019 - 05/2013
2	Inflammation (Inflammations) 03/2024 - 11/2023
2	Melanoma (Melanoma, Malignant) 01/2013 - 12/2012
1	Triple Negative Breast Neoplasms 11/2023
1	Weight Gain 07/2023
1	Atrophy 01/2023
1	Leukemia 07/2022
1	Neurodevelopmental Disorders 03/2021
1	Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi) 03/2021
1	Carotid Artery Diseases 01/2021
1	Drug Resistant Epilepsy 01/2021
1	Phenylketonurias (Phenylketonuria) 01/2019
1	Hypoglycemia (Reactive Hypoglycemia) 11/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Bacterial Vaginosis 05/2015
1	Dysbiosis 04/2015
1	Primary Myelofibrosis (Myelosclerosis) 05/2013
1	Skin Neoplasms (Skin Cancer) 01/2013
1	Cutaneous Malignant Melanoma 01/2013
1	Lymphoma (Lymphomas) 12/2012
1	Muscular Dystrophies (Muscular Dystrophy) 11/2010

4	RNA (Ribonucleic Acid)IBA 11/2023 - 05/2006
3	Butyrates (Butyrate)IBA 11/2023 - 04/2015
3	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2017
1	Interleukin-8 (Interleukin 8)IBA 03/2024
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2023
1	AGRO 100IBA 11/2023
1	APTIBA 11/2023
1	AlbuminsIBA 07/2023
1	Proteins (Proteins, Gene)FDA Link 07/2023
1	OspemifeneIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Volatile Fatty AcidsIBA 03/2021
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 03/2021
1	Histone Deacetylase InhibitorsIBA 03/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 10/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2019
1	16S Ribosomal RNAIBA 01/2019
1	Amino Acids FDA Link 01/2018
1	Succinic Acid (Succinate)IBA 01/2018
1	Biogenic Amines (Biogenic Amine)IBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017
1	EpitopesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	AntigensIBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2015
1	nuclear pore complex protein 98IBA 05/2013
1	Nuclear Pore Complex Proteins (Nucleoporins)IBA 05/2013
1	Codon (Codons)IBA 05/2013
1	Glutamic Acid (Glutamate)FDA Link 01/2013
1	DystrophinIBA 11/2010